15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 3 firms covering Brainsway Ltd, 3 rate it Buy or better, 0 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $17.00 to $18.00, so the covering firms are broadly aligned. The average target of $17.50 sits 11% above the current $15.80. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 2 to 3 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.09 next quarter toward $0.48 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS3 ratings
Moderate Buy
Strong Buy00%
Buy3100%
Hold00%
Sell00%
Strong Sell00%
Based on 3 analysts giving stock ratings to Brainsway Ltd.
As of Jul, 3 of 3 firms rate BWAY a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
BWAY EPS & revenue forecast
EPS · NEXT QUARTER
$0.09
Range $0.06 – $0.13 · 3 analysts · +333% YoY
Next period, 3 analysts expect Brainsway Ltd to earn $0.09 a share (range $0.06 – $0.13), versus $0.02 a year earlier. Full-year consensus is $0.31, growing to $0.48 the year after.
REVENUE · NEXT QUARTER
$17.4M
Range $16.9M – $17.8M · 3 analysts · +29% YoY
Revenue is expected to reach $17.4M (range $16.9M – $17.8M), +28.5% year-over-year. Full-year consensus is $67.6M, rising to $82.6M next year.
Top analysts covering Brainsway Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BWAY.
#1
Raghuram Selvaraju
HC Wainwright & Co. · Rank #249
Buy
$17.00+7.6% to target
Overall win rate
37%
+ Follow
#2
SE
Sam Eiber
BTIG
Buy
$18.00+13.9% to target
Coverage
—
+ Follow
#3
Carl Byrnes
Northland Capital Markets
Buy
$15.00-5.1% to target
Coverage
—
+ Follow
#4
JC
Jeffrey Cohen
Ladenburg Thalmann
Buy
$9.50-39.9% to target
Coverage
—
+ Follow
BWAY stock forecast FAQ
What is BWAY's average 12-month price target?+
The 2 analysts with a live target average $17.50 for Brainsway Ltd over the next 12 months, ranging from a $18.00 high to a $17.00 low.
Is BWAY stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 3 analyst ratings, 3 are Buy or Strong Buy, 0 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for BWAY?+
The Street-high target is $18.00 (BTIG), and the Street-low is $17.00 (HC Wainwright & Co.). The average of all 2 active targets is $17.50.
How many Wall Street analysts cover BWAY?+
3 analysts have an active rating on Brainsway Ltd, and 2 firms carry a live 12-month price target.
Who is the most accurate analyst covering BWAY?+
Among analysts who currently cover BWAY, Raghuram Selvaraju of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #249). Their current call is Buy with a $17.00 target.
What is Brainsway Ltd's projected EPS for next quarter?+
The consensus estimate is $0.09 per share (range $0.06 – $0.13) across 3 analysts. Full-year EPS is projected at $0.31, rising to $0.48 the following year.
How much revenue is Brainsway Ltd expected to report next quarter?+
Consensus revenue is $17.4M (range $16.9M – $17.8M). Full-year revenue is projected at $67.6M, growing to $82.6M next year.
Have analysts been upgrading or downgrading BWAY lately?+
As of Jul, 3 of 3 firms rate BWAY a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BWAY calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.